Bruker Corp. Stock
Bruker Corp. Stock
A very strong showing by Bruker Corp. today, with an increase of €1.31 (3.930%) compared to yesterday's price.
We see a rather positive sentiment for Bruker Corp. with 15 Buy predictions and 1 Sell predictions.
With a target price of 43 € there is a positive potential of 27.07% for Bruker Corp. compared to the current price of 33.84 €.
Our community identified positive and negative aspects for Bruker Corp. stock for the coming years. 0 users see the criterium "Revenue growth" as a plus for the Bruker Corp. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bruker Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bruker Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 3.930% | 6.987% | 14.518% | -3.946% | -17.038% | - | - |
| Healthequity Inc. | 1.490% | -3.597% | -0.741% | -7.586% | -14.103% | 31.373% | 14.765% |
| Omnicell Inc. | 5.560% | -1.351% | -2.013% | 5.036% | -24.742% | -45.926% | -73.929% |
| Myriad Genetics | 5.640% | -4.950% | -4.950% | -45.915% | -27.547% | -81.176% | -83.722% |
Comments
Bruker (BRKR) had its price target lowered by Barclays PLC from $50.00 to $45.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (BRKR) had its price target lowered by Guggenheim from $58.00 to $50.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (NASDAQ:BRKR) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Show more
Ratings data for BRKR provided by MarketBeat
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a